Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease

被引:0
|
作者
Sandra Lemesch
Werner Ribitsch
Gernot Schilcher
Walter Spindelböck
Hildegard Hafner-Gießauf
Gunther Marsche
Lisa Pasterk
Doris Payerl
Bianca Schmerböck
Monika Tawdrous
Alexander R. Rosenkranz
Philipp Stiegler
Gerd Kager
Seth Hallström
Karl Oettl
Katharina Eberhard
Angela Horvath
Bettina Leber
Vanessa Stadlbauer
机构
[1] Medical University of Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology
[2] Medical University of Graz,Department of Internal Medicine, Clinical Division of Nephrology
[3] Intensive Care Unit,Department of Internal Medicine
[4] Medical University of Graz,Department of Surgery, Division of Transplantation Surgery
[5] Institute of Experimental and Clinical Pharmacology,undefined
[6] Medical University of Graz,undefined
[7] Graz,undefined
[8] Institute of Physiological Chemistry,undefined
[9] Center of Physiological Medicine,undefined
[10] Medical University of Graz,undefined
[11] Medical University of Graz,undefined
[12] Core Facility Computational Bioanalytics,undefined
[13] Center for Medical Research,undefined
[14] Medical University of Graz,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Bacterial infection and sepsis are common complications of chronic kidney disease (CKD). A vicious cycle of increased gut permeability, endotoxemia, inadequate activation of the innate immune system and resulting innate immune dysfunction is hypothesized. We assessed endotoxemia, neutrophil function and its relation to oxidative stress, inflammation and gut permeability in patients with CKD grade 3–5 without renal replacement therapy (CKD group, n = 57), patients with CKD stage 5 undergoing haemodialysis (HD, n = 32) or peritoneal dialysis (PD, n = 28) and patients after kidney transplantation (KT, n = 67) in a cross-sectional observational study. In HD patients, endotoxin serum levels were elevated and neutrophil phagocytic capacity was decreased compared to all other groups. Patients on HD had a significantly higher mortality, due to infections during follow up, compared to PD (p = 0.022). Oxidative stress, neutrophil energy charge, systemic inflammation and gut permeability could not completely explain these differences. Our findings suggest that dialysis modality and not renal function per se determine the development of neutrophil dysfunction and endotoxemia in CKD-patients. HD patients are particularly prone to neutrophil dysfunction and endotoxemia whereas neutrophil function seems to improve after KT. Multi-target approaches are therefore warranted to improve neutrophil function and potentially reduce the rate of infections with patients undergoing haemodialysis.
引用
收藏
相关论文
共 50 条
  • [41] Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease
    Conway, Bryan
    Webster, Angela
    Ramsay, George
    Morgan, Neal
    Neary, John
    Whitworth, Caroline
    Harty, John
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) : 1930 - 1937
  • [42] Morbidity, mortality, and renal replacement therapy for chronic kidney disease in Mexico between 2016 and 2018
    Alberto Dorantes-Carrillo, Luis
    Medina-Escobedo, Martha
    Aridai Coba-Canto, Yaseth
    Alvarez-Baeza, Alberto
    Mendez Dominguez, Nina
    NEFROLOGIA, 2022, 42 (03): : 351 - 354
  • [43] Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
    Kotenko, Oleg N.
    Abolyan, Liubov, V
    Kuteinikov, Vladislav Iu.
    Vinogradov, Vladimir E.
    Fomin, Victor V.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (01) : 32 - 37
  • [44] THE COST OF CHRONIC KIDNEY DISEASE BEFORE RENAL REPLACEMENT THERAPY IN MOROCCO: A COST OF ILLNESS STUDY
    Alaoui, Amina Chrifi
    Omari, Mohammed
    Qarmiche, Noura
    Kouiri, Omar
    Chouhani, Basmat Amal
    Houssaini, Tarik Sqalli
    El Fakir, Samira
    Tachfouti, Nabil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 316 - 316
  • [45] METASTATIC PULMONARY CALCIFICATION (MPC) IN A CHILD WITH CHRONIC KIDNEY DISEASE (CKD) IN RENAL REPLACEMENT THERAPY
    Cesca, Laura
    Parolin, Mattia
    Meneghesso, Davide
    Vidal, Enrico
    Benetti, Elisa
    Longo, Germana
    Cavaliere, Annachiara
    Battistel, Michele
    Calabrese, Fiorella
    Murer, Luisa
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1713 - 1713
  • [46] Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study
    Neovius, Martin
    Jacobson, Stefan H.
    Eriksson, Jonas K.
    Elinder, Carl-Gustaf
    Hylander, Britta
    BMJ OPEN, 2014, 4 (02):
  • [47] Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy
    Anna Michalczyk
    Barbara Dołęgowska
    Rafał Heryć
    Dariusz Chlubek
    Krzysztof Safranow
    Lipids in Health and Disease, 18
  • [48] Renal Replacement Therapy in Acute Kidney Injury: Which Mode and When?
    Lobo, Valentine A.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 : S102 - S106
  • [49] Outcomes of Kidney Recipients According to Mode of Pretransplantation Renal Replacement Therapy
    Song, S. H.
    Lee, J. G.
    Lee, J.
    Huh, K. H.
    Kim, M. S.
    Kim, S. I.
    Kim, Y. S.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (07) : 2461 - 2463
  • [50] Kinetics of I 131 in patients with hyperthyroidism combined with chronic kidney disease or end stage kidney disease on renal replacement therapy
    Filipowicz, E.
    Plazinska, M. T.
    Niemczyk, S.
    Kobylecka, M.
    Shebani, Z.
    Giers, K.
    Krolicki, L.
    Rowinska, J. Matuszkiewicz
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S423 - S423